PubMed Health⌕ Search

Biomedical subjects

K F Mori

Publications and source records attributed to K F Mori.

15 recordsLinked to original sources
PubMed1984

A radioreceptor assay method for insulin.

A sensitive and practical radioreceptor assay method for pharmaceutical insulin products has been developed with partially purified rat liver plasma membranes and the optimal conditions under which the best overall assay performance is obtainable have been defined. Intra- and inter-assay variations of the method averaged 7.3 and 12.2% of the man, respectively, when expressed as the coefficient of variation. Potency estimates of an insulin product obtained with the proposed method correlated well with those determined by the mouse convulsion bioassay method. Liver membranes prepared according to the method could be stored for up to ten weeks at 4 degrees C and for 6 months or more at - 18 degrees C without losing insulin-binding ability.

Animals↗
PubMed1977

Partial reduction with dithiothreitol of disulfide bonds in human chorionic gonadotropin.

Of the eleven disulfide bonds of human chorionic gonadotropin (hCG), two were reduced with a 10-fold molar excess of dithiothreitol (DTT) relative to hormone. An S-carboxymethyl (SCM) derivative and a reoxidized product of this reduced hCG retained full biologic activity and were likely to be immunologically identical with native hCG. These two disulfide bonds appeared to be located in the alpha-subunit of the hormone. A 40-fold molar excess of DTT was required to reduce the third disulfide bond which was located in the beta-subunit. An SCM derivative ot this hexa-SH-hCG was only one fifth as biologically active as native hCG but its immunologic activity was only slightly decreased. However, its reoxidized product exhibited over 70% of the biologic activity of and it had nearly the same immunologic activity as the hormone. Reduction of a fourth disulfide bond, probably in the beta-subunit, by a 100-fold molar excess of the reagent was accompanied by considerable alterations in the hormone conformation as evidenced by electrophoresis. The resulting SCM derivatives as well as reoxidized products showed progressive decreases in biologic and immunologic activity and both reduced deca-SCM-hCG and a reoxidized product of deca-SH-hCG were virtually devoid of biologic activity. These findings suggest that the two first-reduced disulfide bonds, apparently in the alpha-subunit, are not important to the biologic activity of the hormone and that the third-reduced disulfide bond, probably in the beta-subunit, is very important in maintaining a biologically active conformation of the hormone. Further disulfide reduction appears to result in considerable alterations in the general conformation of the hormone, including disulfide interchange.

Binding Sites↗
PubMed1977

Carboxypeptidase digestion of human chorionic gonadotropin.

Native human chorionic gonadotropin (hCG) was resistant to carboxypeptidase digestion even in the presence of urea. Isolated alpha subunit of the hormone (hCG-alpha), though unreactive to enzyme treatment in the absence of denaturant, released up to four amino acid residues from the C-terminus on incubation with a mixture of carboxypeptidases A and B in urea. While an hCG-alpha product which lacked Ser-92 recombined completely with intact hCG-beta, hCG-alpha from which Ser-92 recombined completely with intact hCG-beta, hCG-alpha from which Ser-92 and Lys-91 were removed showed only partial recombination. The two recombinants were devoid of any in vivo biologic activity, but retained some of the immunologic activity of the native recombinant. These findings indicate that the integrity of the C-terminal residue of serine in hCG-alpha is essential for the expression of in vivo biologic activity of the native hormone.

Amino Acids↗
PubMed1976

Human chorionic gonadotropin: acetylation of tyrosyls with N-acetylimidazole.

When human chorionic gonadotropin (hCG) was treated with a 20-fold molar excess of N-acetylimidazole in aqueous solution, two tyrosyls were acetylated, resulting in a 50% reduction in in vivo biological activity. With increased quantities of reagent, the number of tyrosyls acetylated increased but with no further decrease in the biological activity. In vitro biological activity (binding to hCG receptors) of the hormone was not affected at all. Acetylation in urea increased tyrosyl modification, accompanied by acetylation of some lysyls, yielding a product in which all seven tyrosyls were acetylated and both in vivo and in in vitro biological activities were completely abolished. Deacylation with hydroxylamine partially restored biological activity of some but not all of the modified products. When individual hCG subunits were treated with the same reagent, the number of tyrosyls acetylated in each subunit again increased with increasing amounts of reagent, up to three in the alpha subunit and two in the beta subunit in the absence of urea. The tyrosyls in the beta subunit appeared less reactive to the reagent than those in the alpha subunit. Subunits modified to these extents retained ability to recombine as examined by gel electrophoresis, but the recombined products varied considerably in both in vivo and in vitro biological activities. A completely tyrosyl-acetylated product of hCG-alpha did not combine with intact hCG-beta, while fully modified hCG-beta did with intact hCG-alpha.

Acetylation↗